NCT07787988Recruiting
Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Randomized Trial
Source: ClinicalTrials.gov · Last updated 6 Oct 2026
Brief summary (registry, in English)
This Hybrid Type 1 cluster randomized trial will test the Peer-led Dynamic Choice HIV Prevention (DCP) intervention compared to standard of care.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 560 (estimated)
- First submitted
- 21 Aug 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 30 Aug 2029
- Lead sponsor
- University of California, San Francisco
- Diseases
- HIV
- NCT number
- NCT07787988
What you commit to
- Study type: Interventional
- Planned participants: 560
- From 1 Oct 2026 to the primary completion date, 30 Aug 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participation in another HIV prevention study
Age
- Aged 15 to \<18 years with no parent or guardian to provide consent
Other
- Contraindication to recommended PrEP/PEP regimen per Ministry of Health guidelines
Who the study is looking for
- Age \>=15 years (with parent/guardian consent required for age 15 to \<18 years)
- Female sex at birth;
- HIV negative by country-standard testing algorithm;
- Elevated risk of HIV exposure, defined as at least 1 of the following: a) eligible for PrEP/PEP based on Uganda Ministry of Health Guidelines or b) work in bar or guesthouse
Age in the registry: 15 years to - · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Infectious Diseases Research Collaboration Coordinator of this site? Confirm its status | Kampala | Uganda | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.